Publicacións en colaboración con investigadores/as de Centre Hospitalier Universitaire de Liège (13)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. The Dubai Definition and Diagnostic Criteria of Laryngopharyngeal Reflux: The IFOS Consensus

    Laryngoscope

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

    The Lancet Respiratory Medicine, Vol. 9, Núm. 3, pp. 260-274

  2. Patients-centered SurvivorShIp care plan after Cancer treatments based on Big Data and Artificial Intelligence technologies (PERSIST): a multicenter study protocol to evaluate efficacy of digital tools supporting cancer survivors

    BMC Medical Informatics and Decision Making, Vol. 21, Núm. 1

2020

  1. A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective

    Patient, Vol. 13, Núm. 3, pp. 317-325

2019

  1. Development of scores assessing the refluxogenic potential of diet of patients with laryngopharyngeal reflux

    European Archives of Oto-Rhino-Laryngology, Vol. 276, Núm. 12, pp. 3389-3404

  2. Evaluation and Management of Laryngopharyngeal Reflux Disease: State of the Art Review

    Otolaryngology - Head and Neck Surgery (United States), Vol. 160, Núm. 5, pp. 762-782

2017

  1. Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 8, pp. 2359-2367

2015

  1. Outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: Systematic review assessing criteria used to define remission and recurrence

    European Journal of Endocrinology, Vol. 172, Núm. 6, pp. R227-R239

2012

  1. Enhanced interpretation of newborn screening results without analyte cutoff values

    Genetics in Medicine, Vol. 14, Núm. 7, pp. 648-655

2011

  1. Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project

    Genetics in Medicine, Vol. 13, Núm. 3, pp. 230-254

2006

  1. Meta- and pooled analysis of GSTT1 and lung cancer: A HuGE-GSEC review

    American Journal of Epidemiology, Vol. 164, Núm. 11, pp. 1027-1042